Clinical Study

Flow-Mediated Vasodilation Is Not Attenuated in Hypertensive Pregnancies Despite Biochemical Signs of Inflammation

Table 1

Clinical characteristics of the 60 women examined during pregnancy and neonatal outcomes. Data is presented as means or number of cases (%), minimums, maximums, and standard deviations.

Control, normal pregnancies
( 𝑁 = 3 2 )
Hypertensive pregnancies
( 𝑁 = 1 6 )
Preeclamptic pregnancies
( 𝑁 = 1 2 )
𝑃 (Kruskall-Wallis test/Chi-square)Pooled
( 𝑁 = 2 8 )
𝑃 (Mann-Whitney U-test)

Age (years)31
(20–39) ± 4.7
30
(21–41) ± 5.9
32
(25–40) ± 5.3
0.56531
(21–41) ± 5.6
0.829
Gestational age at the examination day34
(24–38) ± 3.26
36
(31–38) ± 1.72
33
(25–39) ± 4.53
0.02735
(24–39) ± 3.53
0.187
Nulliparous ( 𝑛 /%)18/56.3%14/87.5%5/41.7%0.03119/68%0.356
(Chi-square)
BMI before pregnancy (kg/m2)22.9
(18.7−28.6) ± 2.91
24.4
(19.3−33.8) ± 4.00
25.5
(19.7−32.5) ± 3.76
0.11224.9
(19.3−33.8) ± 3.87
0.069
Gestational age at birth (weeks)40 weeks
(38−42) ± 10 days
(1.4 weeks)
37 weeks
(33−39) ± 6 days
(0.9 weeks)
39 weeks
(35−40) ± 11 days
(1.5 weeks)
<0.00138
(33−40) ± 11 days
(1.6 weeks)
<0.001
Birth weight (grams)3597
(2360−4700) ± 508
2754
(1775−3620) ± 533
3113
(1975−3960) ± 564
<0.0012907
(1775−3960) ± 565
<0.001
Caesarean section ( 𝑁 /%)5/15.6%6/37.5%3/25.0%0.1349/32.1%0.131
(Chi-square)
Apgar at age of 1 minute/five minutes9/99/98/90.276/0.8318/90.150/0.370
Blood pressure109/69
(91−125/57−81) ± 7.53/6.28
136/89
(118−149/81−99) ± 9.47/5.55
130/88
(107−146/64−99) ± 12.7/11.9
<0.001134/89
(107−149/64−99) ± 11.0/8.70
<0.001